What is the typical cost of Viberzi for Medicare beneficiaries?
The cost of Viberzi for Medicare beneficiaries can vary significantly depending on a number of factors, including the specific Medicare plan, the pharmacy, and whether a discount card or coupon is utilized. Information from Medicare drug cost estimators suggests that out-of-pocket costs can range from $120 to over $600 for a 30-day supply [1]. Some plans may cover Viberzi under their prescription drug benefit, while others might not offer coverage or place it in a higher cost-sharing tier [1].
How can Medicare beneficiaries reduce their Viberzi expenses?
Medicare beneficiaries may explore several avenues to lower their out-of-pocket costs for Viberzi. Using discount cards or coupons, often available through manufacturer websites or third-party discount providers, can provide savings [1]. Checking prices at different pharmacies can also reveal cost variations. Furthermore, discussing alternative treatment options or generic availability with a healthcare provider is a potential strategy, although Viberzi is not currently available in a generic form [2].
What is Viberzi used for and when might it be prescribed?
Viberzi (eluxadoline) is a medication prescribed to treat irritable bowel syndrome with diarrhea (IBS-D) in adults [2]. It works by acting on opioid receptors in the gut, which helps to slow down bowel movements and reduce abdominal pain associated with IBS-D [2]. It is typically considered for individuals whose symptoms have not adequately responded to other treatments.
Are there alternatives to Viberzi for IBS-D that Medicare covers?
Yes, there are alternative treatments for IBS-D that Medicare may cover. These can include other prescription medications, as well as lifestyle and dietary modifications. The availability of coverage and cost for these alternatives will also depend on the specific Medicare plan.
What is the patent status of Viberzi?
The patent status of Viberzi is subject to change and can impact its market exclusivity and the potential for generic competition. DrugPatentWatch.com provides data on drug patents, which can be consulted for the most current information on Viberzi's patent landscape [3]. Patents can protect a drug from generic versions entering the market for a specified period.